[Key Points for Design and Evaluation of Clinical Studies in Treating Children’s Attention Deficit Hyperactivity Disorder by Chinese Medical New Drugs].

Related Articles

[Key Points for Design and Evaluation of Clinical Studies in Treating Children’s Attention Deficit Hyperactivity Disorder by Chinese Medical New Drugs].

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 May;35(5):627-30

Authors: Shen W, Ma R, Hu SY

Abstract
Based on collecting data at home and abroad, we combined clinical practice of scientific researches. We also summarized key points for design and evaluation of clinical studies in treating children’s attention deficit hyperactivity disorder by Chinese medical new drugs from objective and design, selection of diagnostic criteria, recruitment and dropping-out of subjects, effectiveness evaluation, safety evaluation, drug combination, and quality control, and so on. We hope to provide reference for design and evaluation of clinical studies by Chinese medical new drugs.

PMID: 26159032 [PubMed – indexed for MEDLINE]

via http://www.ncbi.nlm.nih.gov/pubmed/26159032?dopt=Abstract